CD4 and systemic lupus erythematosus: A study that examined subsets of CD3+CD4+, CD3+CD4−, and CD3−CD4− lymphocytes in patients with SLE found no significant differences in the levels of IL-12Rβ2 and gp130 on the surface of the subsets studied [49].